Pharmaceutical

Camena bags $10m in funding from Mercia

The bioscience company has received $10m Series A financing from asset manager Mercia.

Jul 3, 2023 - 20:00
Camena bags $10m in funding from Mercia
The bioscience company has received $10m Series A financing from asset manager Mercia.
Read the original article

Tags:

Previous Article

The VPAS fallout continues – Celltrion pulls high-profile biosimilar from UK market

Next Article

Baudax Bio acquires biotechnology firm TeraImmune

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

BMS’s repotrectinib to have FoundationOne genomic sequencing companion diagnostic

BMS’s repotrectinib to have FoundationOne genomic seque...

Apr 12, 2023

NYBC rolls out $50m fund to advance blood and cellular therapy innovations

NYBC rolls out $50m fund to advance blood and cellular ...

May 12, 2023

J&Js Rybrevant plus Lazcluze combination gets FDA approval in NSCLC

J&Js Rybrevant plus Lazcluze combination gets FDA appro...

Aug 21, 2024